SecBot SecBot
SECBOTREPLAY Home › Report › OTLK

OTLK · Outlook Therapeutics received a letter from Nasdaq on June 26, 2026,…

Outlook Therapeutics, Inc. · 8-K filed Jun 26, 2026 at 17:30 ET

At the news

BULLISHIMPACT 5/10

8-K filed Jun 26, 2026 at 17:30 ET

Outlook Therapeutics received a letter from Nasdaq on June 26, 2026, confirming that it has regained compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) after its common stock closed at $1.00 or above for ten consecutive business days from June 11 to June 25, 2026. This resolves the delisting notice received on February 18, 2026, and the matter is now closed, removing a significant overhang on the stock.

  • Nasdaq confirmed compliance with minimum bid price rule on June 26, 2026
  • Stock closed at or above $1.00 for ten consecutive business days (June 11–25, 2026)
  • Delisting matter is now closed
  • Previously notified of non-compliance on February 18, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access